Cellusion
Tokyo
About Cellusion
Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $34.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Jun 2023)
- Website: cellusion.jpen
- Phone: +81.3.5843.1785
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/cellusion-27143 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.